In this study, we first reported the results of a clinical trial using [18F]-S16, a new radioligand for tau tangle imaging, by directly comparing voxel-based cortical uptake of [18F]-S16 and [18F]-THK5317 in the same AD patients and HCs. The gene discussed is MAPT; the disease is Alzheimer disease.